In Vivo Imaging of Oligonucleotides with Nuclear Tomography
Journal:
Current Drug Targets
Volume:
5
Page:
753-760
Author(s):
Adriano Duatti
Extracellular Tropomyosin: A Novel Common Pathway Target for Anti- Angiogenic Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
543-553
Author(s):
Fernando Donate, Keith McCrae, David E. Shaw and Andrew P. Mazar
Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
555-567
Author(s):
Hitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi and Hiroshi Fukui
Targeting Apoptosis Pathways in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
569-576
Author(s):
Simone Fulda and Klaus-Michael Debatin
Chemotherapeutic Agents That Induce Mitochondrial Apoptosis
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
577-590
Author(s):
Tadashi Asakura and Kiyoshi Ohkawa
Proline-Directed Protein Kinase FA as a Potential Target for Diagnosis and Therapy of Human Cancers
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
591-596
Author(s):
Shiaw-Der Yang
Alphaviruses and their Derived Vectors as Anti-Tumor Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
597-607
Author(s):
Gregory J. Atkins, James W. P. Smyth, Marina N. Fleeton, Sareen E. Galbraith and Brian J. Sheahan
The Life Cycle of Cutaneous T Cell Lymphoma Reveals Opportunities for Targeted Drug Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
609-619
Author(s):
Carole L Berger and Richard Edelson
Recent Advances in the Medicinal Chemistry of α-Aminoboronic Acids, Amine-Carboxyboranes and Their Derivatives
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
1001-1018
Author(s):
Valery M. Dembitsky, Abed Al Aziz Quntar and Morris Srebnik
Ruthenium Antimetastatic Agents
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1525-1535
Author(s):
Enzo Alessio, Giovanni Mestroni, Alberta Bergamo and Gianni Sava